Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age
Clinical trial NCT04318548 · COMPLETED
Trial details
- NCT number
- NCT04318548
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-25
- Primary completion
- 2023-11-21
- Enrollment
- 945
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.